708258-08-6 Usage
General Description
2-Quinolinecarboxylic acid, 6-amino-4-hydroxy-(9CI) is a chemical compound that is also known as quinaldic acid. It is a derivative of quinoline with an amino group at the 6th position and a hydroxyl group at the 4th position. Quinaldic acid has been studied for its potential pharmacological properties, including anti-inflammatory and antioxidant effects. It has also been investigated for its role in the synthesis of pharmaceuticals and other organic compounds. Additionally, quinaldic acid has been identified as a potential environmental pollutant and is subject to regulations in some jurisdictions. Its chemical structure and properties make it a subject of interest in various fields of chemistry and biomedicine.
Check Digit Verification of cas no
The CAS Registry Mumber 708258-08-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,0,8,2,5 and 8 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 708258-08:
(8*7)+(7*0)+(6*8)+(5*2)+(4*5)+(3*8)+(2*0)+(1*8)=166
166 % 10 = 6
So 708258-08-6 is a valid CAS Registry Number.
708258-08-6Relevant articles and documents
ANTIBODIES AGAINST SEROTONIN, TRYPTOPHAN AND KYNURENINE METABOLITES AND USES THEREOF
-
Paragraph 0257, (2016/06/20)
The present invention provides antibodies and methods for preparing antibodies to metabolites in the serotonin, tryptophan and kynurenine pathways, such as 5- hydroxyindole-3-acetic acid (5-HIAA), melatonin (MT) and kynurenic acid (KYNA). The specific metabolite antibodies have low cross-reactivity to structurally related metabolites, and are useful reagents for specific and sensitive immunoassays. The present invention also provides methods for using such antibodies to measure the levels of 5-HIAA, melatonin, or kynurenic acid in biological samples from human patients.
2-AMINOCARBONYL-QUINOLINE COMPOUNDS AS PLATELET ADENOSINE DIPHOSPHATE RECEPTOR ANTAGONISTS
-
Page 44, (2010/02/07)
Compounds of formula (I), where m, n, R1, R2, R3, R4 and R6 are described herein, are useful as inhibitors of platelet adenosine diphosphate. Pharmaceutical compositions containing these compounds, methods of using these compounds as antithrombotic agents and processes for synthesizing these compounds are also described herein.
